Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!
Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc.
Our favorite...
American BriVision (ABVC) Reports Completion Clinical Trial for Treatment of Adult ADHD.
American BriVision (ABVC) Reports Completion of ABV-1505 Phase II Part I Clinical Trial for Treatment of Adult ADHD.
Last...
2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.
1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...
SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the COVID-19 Pandemic.
FOR IMMEDIATE RELEASE2020-131
Washington D.C., June 11, 2020 —
The Securities and...
Adding American BriVision (ABVC) $3.30 to Stocks We Expect Double List. $7.00 Price Potential.
Adding to Our 2020 Biotech 5-Pack, 5 Stocks We Expect to Double in 2020
Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.
VANCOUVER, BC, July 17, 2020 /PRNewswire/ - Hapbee Technologies, Inc. ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce...
Immuron (IMRN) to Bank $20 Million.
Another Corona Virus Mania Makes Bank. This time $20 million into Immuron which once struggled, when it was trading near $2.00 just...
Robinhood and Robindhoodette.
The New Force on Wall Street.
It's not hedge funds, it's not program traders or AI-powered portfolio managers....
And Just Like That, We Have Another Double. iBio (IBIO).
$5.35 With 11 Million Shares Traded and it's Not Even 10:00!
Where is Citius Pharma (CTXR) in the FDA Approval Process?
We have a number of subscribers asking for an update on the FDA approval process for Mino-Lok. In layman's term (assuming approval)...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
